Researchers

Professors

At Department of Renal Medicine biomarkers of excessive immunosuppression such as EBV are explored to prevent posttransplant cancer and infections. Experimental pig models are available for prevention of ischaemia reperfusion injury, e.g. using mesenchymal stromal cells and kidney machine perfusion.

Our research team focus on interstitial lung disease to better understand the epidemiology and clinical aspects including the identification of biomarkers. We have a specific focus on how interstitial lung disease affect patients’ quality of life, on symptom management and palliative care.

We study mechanism and treatment of allergy in man; from therapeutic reprogramming of immune response by intralymphatic immunotherapy to diagnostic workup of allergy with the basophil activation test BAT and analysis of IgE-induced primary human mast cell response in vitro. AllergyCenter.au.dk

Macrophages, polarisation, Inflammation, cytokines, tumor associated macrophages, macrophage checkpoints. Biomarkers, assay validation, CD163, CD206, SIRPα, Vitamin D. Immunotherapy, myeloma, microenvironment, microparticles, targeted therapy. Multiplex ELISA, Nanosight, LCMS, Automated assays.

My group investigates the role of extracellular vesicles (exosomes) in host-parasite interactions and the immune-modulatory properties of parasitic worms. We aim to develop new diagnostic methods and to understand how parasites manipulate our immune system to provide novel treatment options.

The focus of my research is understanding differential susceptibility to severe infectious diseases in humans. We study the role of host genetics and immune responses in herpesvirus infections of the brain as well as influenza and COVID19 and use this knowledge to improve diagnosis, prophylaxis and treatment of patients.

Associate Professors

Reseach focus: Clinical and epidemiologica aspects of hepatitis C. Project involving screening for hepatitis B and C among risk groups. As member of Guinea Bissau HIV study group we look improvement of the treatment cascade and diagnistics of opportunistic infections.

We use health-services research as the underlying basis for our research, and aim to explore new models of care within rheumatology. We have a special interest in the use of telemedicine solutions, remote control, web-based patient education and the use of patient reported outcomes.

My group aims to understand the epidemiology and treatment aspects for HIV and tuberculosis, with a focus on global aspect of infectious diseases, in low resource settings. Additionally we aim to describe infections and other health aspects in refugees and other migrants.



We are interested in understanding the underlying molecular mechanisms involved in chronic inflammatory skin diseases with a central focus on psoriasis. Our goal is to identify specific inflammatory factors and signaling pathways that are essential to the disease pathogenesis, and to transform these findings into novel therapeutic strategies.

The main interest of the laboratory is aquaporin (AQP) water channels. We especially focus on renal AQP2, which plays a vital role in regulation of body water balance via fine-tuning of urine concentration, and the role of AQPs in cancer.


My research focus on understanding the clinical epidemiology of thrombosis and bleeding disorders e.g. disseminated intravascular coagulation, with particular attention to occurrence, prevention, role of biomarkers, treatment, risk factors, and prognosis.

I study viral infections and human immune responses. I seek to explore adaptive and innate immune modulation and develop novel immunotherapy treatments. I work on implementing novel treatments through clinical trials and to study virology and immunology in humanized mice and in primary cell culture.

We investigate microbiological, clinical, and biochemical aspects of pharyngeal infections. Our vision is to clarify the significant pathogens associated with these infections and improve the medical and surgical treatment regimens.